New thoughts on the pathobiology of regimen-related mucosal injury

被引:26
作者
Anthony, Lowell
Bowen, Joanne
Garden, Adam
Hewson, Ian
Sonis, Stephen
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[3] LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA USA
[4] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
[5] Royal Adelaide Hosp, Dept Med Oncol, Adelaide, SA 5000, Australia
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
mucosal injury; cancer theraphy; radiation; drugs; genetic influences;
D O I
10.1007/s00520-006-0058-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Our understanding of the biological basis for mucosal barrier injury (mucositis) induced by cancer therapy with radiation or drugs continues to evolve. A patient's mucosal response to cancer therapy appears to be controlled by both global (i.e. gender, underlying systemic disease, race) and tissue specific (i.e. epithelial type, intrinsic endocrine system, local microbial environment, function) factors. Conclusion: Interactions of these elements, coupled with underlying genetic influences, most likely govern the risk, course and severity of regimen-related mucosal injury.
引用
收藏
页码:516 / 518
页数:3
相关论文
共 19 条
  • [1] Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions
    Barasch, A
    Peterson, DE
    [J]. ORAL ONCOLOGY, 2003, 39 (02) : 91 - 100
  • [2] Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor
    Beck, PL
    Wong, JF
    Li, Y
    Swaminathan, S
    Xavier, RJ
    Devaney, KL
    Podolsky, DK
    [J]. GASTROENTEROLOGY, 2004, 126 (03) : 796 - 808
  • [3] Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview
    Blijlevens, NMA
    Donnelly, JP
    De Pauw, BE
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1269 - 1278
  • [4] Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans
    Bowen, JM
    Gibson, RJ
    Keefe, DM
    Cummins, AG
    [J]. PATHOLOGY, 2005, 37 (01) : 56 - 62
  • [5] Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
    Chansky, K
    Benedetti, J
    Macdonald, JS
    [J]. CANCER, 2005, 103 (06) : 1165 - 1171
  • [6] Circadian variation of topoisomerase II-α in human rectal crypt epithelium:: Implications for reduction of toxicity of chemotherapy
    Clayton, F
    Tessnow, KA
    Fang, JC
    Holden, JA
    Moore, JG
    [J]. MODERN PATHOLOGY, 2002, 15 (11) : 1191 - 1196
  • [7] Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119
  • [8] Differential sensitivity to apoptosis between the human small and large intestinal mucosae:: Linkage with segment-specific regulation of BCL-2 homologs and involvement of signaling pathways
    Gauthier, R
    Laprise, P
    Cardin, É
    Harnois, C
    Plourde, A
    Reed, JC
    Vézina, A
    Vachon, PH
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 82 (02) : 339 - 355
  • [9] Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy
    Grötz, KA
    Genitsariotis, S
    Vehling, D
    Al-Nawas, B
    [J]. SUPPORTIVE CARE IN CANCER, 2003, 11 (11) : 717 - 721
  • [10] HUANG FS, AM J PHYSL GASTROINT, V282, pG432